Stay alert, beware of scamsters - know more

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open151.4
High154.9
Low146
Prev. Close148.02
Avg. Traded Price153.1
Volume1,09,884

MARKET DEPTH

info2
Total bid39669.00
Total ask34430.00
OrdersQtyBid
31066151
150150.7
1100150.65
115150.6
15150.4
AskQtyOrders
152.922021
1531100
153.5125
1543521
154.36195

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

151.902 days ago
151.902 days ago
arrow

LOWER/UPPER CIRCUITS

151.90
158.10
arrow
Gaudium Ivf And Women Health Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral

Our researchers has found no immediate positive insights for this stock. We'll update this space as soon as we find something.

Gaudium IVF and Women Health was originally incorporated in the name of ‘Gaudium IVF and Women Health Private Limited’ as a private limited company on March 24, 2015. Subsequently, the company was converted from a private limited company into a public limited company pursuant to a special resolution passed in the extraordinary general meeting of the shareholders held on September 28, 2024 and consequently, the name of the company was changed to ‘Gaudium IVF and Women Health Limited’.The company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. The company has patients from different countries such as Canada, United Kingdom, United State, Kenya, South Africa and Oman.

The company’s Main centers (Hubs) are located in major cities to cater potential locations across India.The company offers a complete array of specialized fertility and reproductive health services. Its advance treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction, all its treatments are carefully designed to address a variety of infertility challenges for both male and female. The company also offers comprehensive gynaecological care, including PCOD/PCOS and endometriosis.

Further, high-risk pregnancy management is provided for women with complex fertility histories or health conditions. The wellness aspect includes fertility wellness programs, offering nutritional counselling and psychological support to ensure holistic care for couples undergoing treatments.Business area of the companyThe company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. The company has patients from different countries such as Canada, United Kingdom, United State, Kenya, South Africa and Oman.

The company’s Main centers (Hubs) are located in major cities to cater potential locations across India.Services of the companyFertility TreatmentIVF treatment, or in vitro fertilizationIntrauterine Insemination (IUI)Intracytoplasmic Sperm Injection (ICSI)Polycystic Ovarian Syndrome (PCOS), also known as polycystic ovarian disease (PCOD)Male InfertilityEndometriosis TreatmentOvulation Induction (OI)Laser Assisted Embryo ImplantationInfertility SurgeriesSurrogacyHospital FacilityPharmacy serviceAwards, accreditations and recognition2016: Asia's Greatest Brand.2018: Symbol of Brand Excellence Award.2019: India Best Practices Award- IVF Chain Company of the Year.2022: Highly Prestigious Quality Choice Award.2023: Holistic Healthcare Brand Leader of the Year.History and milestones2015: Incorporation of the company.2019: The company started Gaudium Hospital.2021: Acquired the Gaudium IVF Gynae Solutions, Proprietor Business of Dr. Manika Khanna: Janakpuri Center (opened in 2009), Greater Kailash Center (opened in 2016), Patna Center (opened in 2019).2021: The company started Mumbai Center (Maharashtra).2023: Acquired Gaudium Brand.2023: Acquired 100% shares of Gaudium International Private Limited.2023: Acquired Gaudium Bawa Ludhiana Center.2023: The company started Bangalore Centre (Karnataka).2024: The company started Srinagar Centre (Jammu Kashmir).2024: Conversion of company from Private to Public.

personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

For Q4 FY26, Gaudium Ivf And Women Health Ltd reported: Revenue (Net Sales): ₹221.66 Cr - Up 56.18% year-on-year from ₹141.93 Cr in Q3 FY26. Net Income (PAT): ₹77.31 Cr - Up 142.88% year-on-year from ₹31.83 Cr in Q3 FY26.

As of 25 Jul 2026, the share price of Gaudium Ivf And Women Health Ltd is ₹151.90 on the NSE and ₹151.45 on the BSE. The stock opened at ₹158.49, touched a high of ₹155.00 and a low of ₹151.90 during today's session.

Over the last 6 months, Gaudium Ivf And Women Health Ltd has given a return of 89.26%. The stock was priced at ₹N/A on N/A and has risen to ₹151.90 as of 25 Jul 2026, a change of ₹N/A per share.

No,Gaudium Ivf And Women Health Ltd has not declared any dividend over the past 5 years. The company paid a total dividend of N/A per share between FY2022 and FY2026, with the most recent dividend of ₹N/A per share. At the current market price of ₹151.90, the trailing dividend yield of Gaudium Ivf And Women Health Ltd stands at N/A%.

Gaudium Ivf And Women Health Ltd has delivered a N/A% absolute return over the past 5 years, equivalent to a CAGR of N/A% per annum. The stock was priced at ₹N/A in Jul 2021 and has fallen to ₹151.90 as of 25 Jul 2026. An investment of ₹1,00,000 in Gaudium Ivf And Women Health Ltd five years ago would be worth ₹N/A today.

Gaudium Ivf And Women Health Ltd has delivered 89.26% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹163.18 on 22 Jul 2026 and a 52-week low of ₹69.18 on 23 Mar 2026. It is currently trading at ₹151.90 as of 25 Jul 2026.

The all-time high (ATH) for Gaudium Ivf And Women Health Ltd was ₹158.16, recorded on 22 Jul 2026. At the current price of ₹151.90, the stock is trading 3.96% below its all-time high. The all-time low recorded was ₹70.67 on 23 Mar 2026.

The intraday low for Gaudium Ivf And Women Health Ltd on the NSE today was ₹151.90. The stock's 52-week low stands at ₹69.18, recorded on 23 Mar 2026. Today's low is 119.57% above the 52-week low, indicating the stock is trading well above its yearly lows.

Gaudium Ivf And Women Health Ltd has delivered a return of 18.51% over the last 3 months. The stock was trading at ₹124.39 on 24 Apr 2026 and is currently at ₹151.90 as of 25 Jul 2026, reflecting a Gain of ₹27.51 per share over this period.

The intraday high for Gaudium Ivf And Women Health Ltd on the NSE today (25 Jul 2026) was ₹155.00. This compares to the 52-week high of ₹163.18 recorded on 22 Jul 2026. Today's high was -5.01% below the 52-week high.

+91
Offer Banner Trigger
Offer Banner

Open a FREE Demat Account

+91